普昂医疗完成IPO辅导：董事长胡超宇夫妇控股59%，妻子毛柳莺曾有7年未就业

Core Viewpoint - Puang Medical Technology Co., Ltd. is preparing for an IPO on the Beijing Stock Exchange, having completed its guidance work with Guojin Securities as the advisory institution [2]. Financial Performance - In 2024, Puang Medical achieved operating revenue of 318.03 million yuan, representing a year-on-year increase of 34.61% [3]. - The net profit for the same period was 64.88 million yuan, up 41.34% compared to the previous year [3]. - The gross profit margin improved to 49.44%, compared to 47.20% in the previous year [3]. Shareholding Structure - The legal representative and chairman, Hu Chaoyu, directly holds 42,079 shares (0.10%) and indirectly controls 28.54% of the voting rights through Taiyouhong, 26.13% through Pumao Partnership, and 4.72% through Hangzhou Youying [4]. - Hu Chaoyu and his spouse, Mao Liuying, collectively control 59.49% of the voting rights, making them the actual controllers of the company [4]. Company Background - Puang Medical was established in January 2013, focusing on the research, production, and sales of diabetes care, general drug infusion, and minimally invasive medical devices [2]. - The registered capital of the company is 42.33 million yuan [2].